- Home
- NMR vs BMRN Comparison
NMR vs BMRN Comparison
Compare NMR & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMR
- BMRN
- Stock Information
- Founded
- NMR 1925
- BMRN 1996
- Country
- NMR Japan
- BMRN United States
- Employees
- NMR 27344
- BMRN N/A
- Industry
- NMR Investment Bankers/Brokers/Service
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- NMR Finance
- BMRN Health Care
- Exchange
- NMR Nasdaq
- BMRN Nasdaq
- Market Cap
- NMR 16.3B
- BMRN 12.1B
- IPO Year
- NMR 1961
- BMRN 1999
- Fundamental
- Price
- NMR $5.57
- BMRN $59.82
- Analyst Decision
- NMR Hold
- BMRN Buy
- Analyst Count
- NMR 1
- BMRN 22
- Target Price
- NMR N/A
- BMRN $93.43
- AVG Volume (30 Days)
- NMR 1.1M
- BMRN 1.6M
- Earning Date
- NMR 04-25-2025
- BMRN 05-01-2025
- Dividend Yield
- NMR 3.75%
- BMRN N/A
- EPS Growth
- NMR 110.70
- BMRN 152.82
- EPS
- NMR 0.74
- BMRN 2.71
- Revenue
- NMR $12,637,799,087.00
- BMRN $2,950,227,000.00
- Revenue This Year
- NMR $20.38
- BMRN $12.27
- Revenue Next Year
- NMR N/A
- BMRN $9.86
- P/E Ratio
- NMR $7.20
- BMRN $22.11
- Revenue Growth
- NMR 21.16
- BMRN 19.36
- 52 Week Low
- NMR $4.66
- BMRN $52.93
- 52 Week High
- NMR $6.99
- BMRN $94.85
- Technical
- Relative Strength Index (RSI)
- NMR 46.65
- BMRN 40.34
- Support Level
- NMR $5.48
- BMRN $60.92
- Resistance Level
- NMR $5.59
- BMRN $65.40
- Average True Range (ATR)
- NMR 0.08
- BMRN 1.96
- MACD
- NMR 0.03
- BMRN 0.06
- Stochastic Oscillator
- NMR 38.46
- BMRN 21.52
About NMR Nomura Holdings Inc ADR
Nomura Holdings Inc is a financial services group in Japan and operates offices in countries and regions worldwide including Japan, the U.S., the U.K., Singapore, and the Hong Kong Special Administrative Region ("Hong Kong") through its subsidiaries. The company's clients include individuals, corporations, financial institutions, governments, and governmental agencies. The company's business consists of Wealth Management*, Investment Management, and Wholesale. The company generates the majority of its revenue from the wholesale segment. The Wholesale Division consists of two businesses, Global Markets, which is mainly engaged in the trading, sales, and structuring of financial products, and Investment Banking which is engaged in advisory, financing, and solutions businesses.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.